Original news and analysis on international IP policy
An academic conference this month will explore issues related to innovation, research and competition in the European Union, addressing topics such as 5G, big data, patents and standards.
The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research and development costs, and greater transparency, according to participants.
The World Health Organization today published an item entitled, Access to medicines: making market forces serve the poor, a chapter from its report ‘Ten years in public health 2007-2017’ of outgoing WHO Director General Margaret Chan.
Two new studies published by the World Health Organization provide insight on the production of pharmaceutical products in India and China. According to the studies, China has a substantial local pharmaceutical manufacturing sector which the Chinese government is closely linking to its policy objective of universal health care. India, the main global provider of generic medicines is not pursuing a comparable focus on universal health care. India is increasingly faced with Chinese pharmaceutical sector competition, with China being its main provider of commoditized active pharmaceutical ingredients (APIs).
After prevaricating for about three years, the European Union now seems to be about to ratify a treaty lifting copyright across borders for books in special format for visually impaired people. The European Blind Union saluted the agreement as great news for millions of people with visual disabilities but warned that a provision allowing EU members to impose economic compensation on organisations representing blind persons and libraries could run counter to the benefit of the treaty.
A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics.
The 18th round of the Regional Comprehensive Economic Partnership (RCEP) trade agreement negotiations is taking place this week in Manila, Philippines. Health activists warn that Japan and South Korea are pushing for measures that go beyond international trade rules on intellectual property, including extending patent terms and data exclusivity in countries such as India, a primary source of cheaper generic medicines.
Efforts by the newly elected chair of the World Intellectual Property Organization copyright committee, and ongoing studies and initiatives commissioned by WIPO to move past irreconcilable differences on limitations and exceptions to copyright, had little effect last week in terms of agreeing a work programme. However, the committee agreed to ask the WIPO secretariat to propose a draft action plan on those items, and also adopted a new version of a text on the protection of broadcasting organisations. But there was no agreement on recommending to the annual General Assemblies in October to convene a diplomatic conference to finish negotiations on a broadcasting treaty.
In a talk at the re:publica 2017 in Berlin this week, academics from the Share Lab Project presented how they relied on an unusual resource to get a measure of the algorithms of Facebook. By reading through a part of the 8000 patents registered by the company, the researchers were able to shed some light into the process of how the "Empire" turns the raw data they treat their users as into those valuable big data golden profiles that then can be marketed.
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy.
There is growing worry and resentment among music performers around the world about the low level of their remuneration and the fact that they are mostly missing their share of the internet music streaming pie, according to speakers at an event held at the World Intellectual Property Organization this week. Performers need a change in international rules, in particular a right to remuneration, they said.
Since the passage of the America Invents Act (“AIA”) in 2011, Inter Partes Reviews (“IPRs”) before the Patent Trial and Appeal Board (“PTAB”) have assumed growing importance in patent litigation in federal district courts. Until recently, IPRs have not played a significant role in International Trade Commission (“ITC”) Section 337 investigations. While the ITC is unlikely to stay a Section 337 investigation, pending IPRs will likely have an increasing impact at the ITC, especially when an IPR proceeding reaches an advanced stage before or during the pendency of a Section 337 investigation. This article examines the limited interplay to date between IPRs and Section 337 proceedings and discusses potential implications for future investigations.